PM2C hosts second event in the MOHCCN Seminar Series
Researchers from the MOHCCN's Princess Margaret Cancer Centre Consortium (PM2C) presented during the second event of the Marathon of Hope Cancer Centres Network Seminar Series.
The event included presentations by Drs. Philippe Bedard, Lillian Siu and Alberto Hernando Calvo.
You can watch the entire presentation, below:
The event included presentations by Drs. Philippe Bedard, Lillian Siu and Alberto Hernando Calvo.
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
Related News
-
New study shows how comprehensive sequencing and molecular tumour boards can help put precision oncology into practice
Precision oncology is a promising approach for personalized cancer treatments. A new study from a Network-funded team demonstrates how it can be put into practice, and the challenges that remain to ma... -
Princess Margaret Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
New computational tool provides clues on how to target cancers with KMT2D mutations
A new study led by Dr. Marco Marra describes a strategy for identifying potential novel treatment targets in cancers driven by the loss of genes that are classified as tumour suppressors. -
Atlantic Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing...
